Adjuvant Melatonin for Uveal Melanoma — Stella

stellabeta Find trials matched to me Trial Match

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Recruiting

Back to Uveal Melanoma trials

Phase 3 — Testing in thousands of people, comparing the treatment against what doctors currently use. This is the last big step before approval.

Trial locations(1 site)

Sweden

St. Erik Eye Hospital, Stockholm, Stockholm County

Key details

Phase

Large-scale testing

Sponsor

Gustav Stalhammar

Collaborators

Karolinska Trial Alliance, The Swedish Eye Foundation (Ögonfonden)

Enrollment target

~100 participants

Started

October 2022

Primary completion

January 2031

Age range

18 Years and older

Last updated May 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov

Adjuvant Melatonin for Uveal Melanoma — Stella